1 completed, 1 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Hyperlipidaemia: new trials by email Literature Review of Hyperlipidaemia trials Research Report on Hyperlipidaemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease. The test product is a ready-to-use sinbiotic preparation of multispecies probiotics, ca-butyrate and FOS, Placebo Drug - MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Diabetes Mellitus | Phase 2 | Not yet recruiting | Eva Cubric | 114 | 2025-07-01 | 2025-06-18 |
| A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia AZD8233, Placebo - Hyperlipidaemia | Phase 2 | Completed | AstraZeneca | 411 | 2021-07-07 | 2023-12-15 |
Hyperlipidemias (2) · Diabetes Mellitus (1) · Hypertension (1) · Metabolic Syndrome (1)
Dyslipidemias (2) · Lipid Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Cardiovascular Diseases (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Insulin Resistance (1) · Vascular Diseases (1)
AstraZeneca (1) · Eva Cubric (1)
Croatia (1) · Czechia (1) · Denmark (1) · Hungary (1) · Netherlands (1) · Poland (1) · Slovakia (1) · Spain (1) · United States (1)
Marko Skelin, ass.prof.dr.sc, mag.pharm. (1)